Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
Clinical trial NCT05275504 · UNKNOWN
Trial details
- NCT number
- NCT05275504
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-09-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.